Early-start Exercise Training in Subacute Heart Failure
RE-START
1 other identifier
interventional
200
1 country
9
Brief Summary
The purpose of this study is to evaluate the feasibility and the short-term effects of an early-start aerobic exercise training program on functional capacity, symptoms and neurohormonal activation in chronic heart failure patients with recent acute hemodynamic decompensation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2013
Typical duration for not_applicable
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2013
CompletedFirst Submitted
Initial submission to the registry
January 29, 2014
CompletedFirst Posted
Study publicly available on registry
January 31, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2015
CompletedJanuary 31, 2014
January 1, 2014
1.7 years
January 29, 2014
January 29, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Distance walked at 6-min walking test
Change from baseline in distance walked at 6-min walking test
12 days of intervention
Secondary Outcomes (4)
Aerobic exercise training safety and tolerability
12 days of treatment
Patient-reported dyspnea, evaluated by a 7-point Likert scale
12 days of intervention
Levels of lymphocyte G protein-coupled receptor kinase-2
12 days of intervention
Levels of circulating inflammatory and angiogenetic markers (TNF-alfa, Interleukin-6, Angiopoietin 2 and VEGF)
12 days of intervention
Study Arms (2)
Aerobic exercise training
EXPERIMENTALStandard physical therapy
ACTIVE COMPARATORInterventions
Days 1-2: active assisted mobilization (2 sessions/day, each 30 minutes duration). Days 3-4: as days 1-2 + unloaded bedside cycle ergometer (3 sessions/day, each 5-6 minutes duration). Days 5-6: as days 1-2 + bedside cycle ergometer at 10 W (3 sessions/day, each 15-20 minutes duration). Days 7-12: as days 1-2 + bedside cycle ergometer at 10-20 W (3 sessions/day, each 15-20 minutes duration). In addition, when possible according to their clinical conditions, patients will undergo one assisted ambulation session of 15-20 minutes per day.
Days 1-2: active assisted mobilization (2 sessions/day, each 30 minutes duration). Days 3-12: active assisted mobilization (1 session/day, 30 minutes duration). In addition, when possible according to their clinical conditions, patients will undergo one assisted ambulation session of 15-20 minutes per day.
Eligibility Criteria
You may qualify if:
- history of chronic heart failure for at least 6 months, with ongoing acute decompensation defined as onset or worsening of heart failure signs and/or symptoms during the previous 15 days with need of intravenous diuretic and/or vasodilator therapy;
- age \>18 years
- left ventricular ejection fraction \<40%
- proBNP \>1000 pg/ml at admission
You may not qualify if:
- ongoing cardiogenic shock
- need of intravenous inotropic therapy
- acute coronary syndrome during the preceding 3 months
- clinical and/or instrumental evidence of myocardial ischemia and/or life-threatening arrhythmias
- previous cardiac valve surgery
- creatinine \>2.5 mg/dl at admission
- severe comorbidities limiting functional capacity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (9)
Fondazione Salvatore Maugeri, IRCCS - Scientific Institute of Cassano Murge
Cassano Murge, 70020, Italy
Fondazione Salvatore Maugeri, IRCCS - Scientific Institute of Lumezzane
Lumezzane, 25066, Italy
Fondazione Salvatore Maugeri - Scientific Institute of Milano
Milan, 20138, Italy
Fondazione Salvatore Maugeri, IRCCS - Scientific Institute of Montescano
Montescano, 27040, Italy
Fondazione Salvatore Maugeri, IRCCS - Scientific Institute of Pavia
Pavia, 27100, Italy
Fondazione Salvatore Maugeri, IRCCS - Scientific Institute of Telese Terme
Telese Terme, 82037, Italy
Fondazione Salvatore Maugeri - Presidio Major of Torino
Torino, 10124, Italy
Fondazione Salvatore Maugeri, IRCCS - Scientific Institute of Tradate
Tradate, 21049, Italy
Fondazione Salvatore Maugeri, IRCCS - Scientific Institute of Veruno
Veruno, 28010, Italy
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Pantaleo Giannuzzi, MD
Fondazione Salvatore Maugeri - Scientific Institute of Veruno
- PRINCIPAL INVESTIGATOR
Alessandro Mezzani, MD
Fondazione Salvatore Maugeri - Scientific Institute of Veruno
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
January 29, 2014
First Posted
January 31, 2014
Study Start
October 1, 2013
Primary Completion
June 1, 2015
Study Completion
September 1, 2015
Last Updated
January 31, 2014
Record last verified: 2014-01